Oragenics
OGEN
13 hedge funds and large institutions have $136K invested in Oragenics in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
8% more funds holding
Funds holding: 12 → 13 (+1)
0.06% less ownership
Funds ownership: 0.14% → 0.08% (-0.06%)
50% less capital invested
Capital invested by funds: $269K → $136K (-$134K)
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$24.9K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$17.2K |
| 3 |
LWM
Lionsbridge Wealth Management
Jacksonville Beach,
Florida
|
+$15.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.49K |
| 5 |
AWM
Activest Wealth Management
Aventure,
Florida
|
+$45 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$60.4K |
| 2 |
Renaissance Technologies
New York
|
-$51.1K |
| 3 |
VF
Virtu Financial
New York
|
-$15.8K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$14.8K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.22K |
OGEN Hedge Fund Activity: Q2 2024 in Review
13 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q2 2024, worth a combined $136K — down 50% from $269K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new OGEN positions and 3 closed out — a net gain of 1 holder — while 2 added to existing stakes and 5 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $24.9K. The largest seller was Warberg Asset Management, cutting an estimated $60.4K.
- 13 institutional investors held Oragenics (OGEN) as of Q2 2024, up from 12 in Q1 2024.
- Funds reported $136K of Oragenics stock for Q2 2024, down 50% quarter-over-quarter.
- 4 funds opened new Oragenics positions in Q2 2024 and 3 closed out, a net change of +1 holder.
- The largest Oragenics buyer in Q2 2024 was Citadel Advisors, an estimated $24.9K added.
- The largest Oragenics seller in Q2 2024 was Warberg Asset Management, an estimated $60.4K sold.
Based on aggregated 13F filings for Q2 2024.